Skip to main content
Rural Health Information Hub

Rural Pharmacy and Prescription Drugs – News

News stories from the past 60 days.

Nov 21, 2022 - Notice from the Centers for Disease Control and Prevention (CDC) announcing the availability of the CDC Clinical Practice Guideline for Prescribing Opioids for Pain—United States, 2022 (2022 Clinical Practice Guideline). The 2022 Clinical Practice Guideline updates and expands the CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 (2016 Guideline) and provides evidence-based recommendations for clinicians who provide pain care, including those prescribing opioids, for outpatients aged 18 years and older with acute pain, subacute pain, or chronic pain.
Source: Federal Register
Nov 9, 2022 - Notice of proposed rule from the U.S. Department of Health and Human Services (HHS) updating versions of the retail pharmacy standards for electronic transactions adopted under the Administrative Simplification subtitle of the Health Insurance Portability and Accountability Act (HIPAA). Among other things, this proposed rule will modify the currently adopted standards for the following retail pharmacy transactions: healthcare claims or equivalent encounter information; eligibility for a health plan; referral certification and authorization; and coordination of benefits. Comments are due by January 9, 2023.
Source: Federal Register
Oct 28, 2022 - The Health Resources and Services Administration (HRSA) is seeking comment on revisions to forms related to the enrollment and recertification of covered entities in the 340B Drug Pricing Program. Comments are due by November 28, 2022.
Source: Federal Register
Oct 19, 2022 - Executive Order from the Office of the President directing the Secretary of Health and Human Services (HHS) to consider whether the Center for Medicare and Medicaid Innovation should test new payment and delivery models that would lower drug costs and promote access to innovative drug therapies for Medicare and Medicaid program beneficiaries. The Secretary of HHS must submit a report to the Assistant to the President for Domestic Policy outlining and describing models to be tested and implementation plans.
Source: Federal Register
Oct 18, 2022 - Describes the effects of rural pharmacy closures on communities and the role that pharmacies play in the fabric of rural communities. Notes challenges for financial viability due to population declines and competition with large chain pharmacies, highlighting the perspective of a rural pharmacist in Tennessee.
Source: News 5 Cleveland
Oct 14, 2022 - Notice from the Centers for Medicare & Medicaid Services (CMS) establishing the Medicare Drug Rebate and Negotiations Group within the Center for Medicare to implement the Drug Price Negotiation Program and the Inflation Rebate Program in Medicare Part B and Part D as authorized under the Inflation Reduction Act of 2022. The Drug Price Negotiation Program group will negotiate drug prices with pharmaceutical manufacturers for certain Part B and Part D drugs, and the Inflation Rebate Program will determine which drugs had price increases exceeding inflation and compute, invoice, and collect rebates owed by manufacturers. This reorganization is effective October 8, 2022.
Source: Federal Register

Last Updated: 11/21/2022